The recent partnership between Oura and Eli Lilly has raised considerable attention across the healthcare industry. At first glance, it looks like another collaboration between a technology company and a pharmaceutical manufacturer. However, looking deeper, it signals a broader transformation that could introduce new aspects on how patients are monitored throughout their treatment journey. … Continue reading From Wearables to Real-World Evidence: Are We Ready for Consumer-Generated Health Data?
Tag: Methodology
The Practical Applications of AI in Real-World Evidence Studies
Artificial intelligence has become a very frequently discussed topic also in real-world evidence (RWE) research, registries, and clinical data science. Conferences, publications, and industry reports routinely highlight AI as a transformative force capable of accelerating evidence generation, improving data quality, and expanding the utility of healthcare data. However, much of this discussion remains high… Continue reading The Practical Applications of AI in Real-World Evidence Studies
When the Real World Emerges from the Trial Shadow: Cardiovascular RWE at an Inflection Point
by Mathieu Ghadanfar, MD, FESC, FAHA Cardiovascular medicine has entered an era of extraordinary randomized evidence. DAPA-HF, EMPEROR-Reduced, EMPA-KIDNEY, the SELECT trial (1, 2, 3): each enrolling tens of thousands of patients, each reshaping guidelines. And yet the questions that dominate daily clinical decision-making remain unanswered by any of them. No large randomized… Continue reading When the Real World Emerges from the Trial Shadow: Cardiovascular RWE at an Inflection Point
Real-World Evidence Without Data Ownership: How CROs Compete on Execution
The growing role of real-world evidence (RWE) across research, development, and decision-making has provided new opportunities for contract research organizations (CROs) operating in this space. However, the market of CROs delivering RWE is structurally unequal. With the notable exception organizations with proprietary data assets such as IQVIA, most CROs do not own large-scale proprietary healthcare… Continue reading Real-World Evidence Without Data Ownership: How CROs Compete on Execution
Using Real-World Data to Drive Precision Nutrition for Endurance Athletes
In Endurance Sports, Nutrition Is Not Advice, It’s an Intervention From Endurance Sport to Precision Nutrition Not many people who know me as a Real World Data professional in pharma are aware that I also run a side activity in precision nutrition for endurance athletes. This work began naturally, driven by my personal… Continue reading Using Real-World Data to Drive Precision Nutrition for Endurance Athletes